파로스아이바이오 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 윤정혁, was filed 04 Jun 2026.
파로스아이바이오: what insiders have been doing
Every trade that managers of 파로스아이바이오 disclose to DART (FSS) is tracked on this page. The company sits in the Health Care sector. In the past year (8 November 2025 to 8 November 2026), 4 filings came from 3 insiders.
On the market, 2 insiders bought (2 purchases totalling €52k) while 2 insiders sold (2 sales). No amount is published for 3 filings, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The largest single trade was a purchase of €52k by 윤정혁, published on 4 June 2026.
The last purchase on record was published on 4 June 2026, which is 159 days ago. Filings reach the DART (FSS) feed a median of 7 days after the trade. That lag is the time during which only the insider knows about the trade.
With 4 filings in twelve months, the company is quieter than the median of 7 filings across the 2,657 companies we follow on the same exchange. The full history, which starts in 2023, counts 9 purchases against 2 sales.
In the same sector, recent insider purchases at Dynavox Group AB and Vetoquinol SA also feature in our signals. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleThis score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2022FY ended December 2022 · cache
- 15,000 shares@ ₩6,142.00100.0% of flowShareKRXDART:20260604000150Canonical exit: 2 Sept 2026 (T+90)
- 249,673 sharesKRXDART:20260116000302
- 240,000 sharesShareKRXDART:20260116000279
- 199,251 sharesKRXDART:20260109000564Canonical exit: 17 Mar 2026 (T+90)
- ShareKRXDART:20240930000146Canonical exit: 26 Dec 2024 (T+90)
- 199,251 sharesKRXDART:20230814000347Canonical exit: 6 Nov 2023 (T+90)
- ShareKRXDART:20230803000209
- ShareKRXDART:20230803000199
- ShareKRXDART:20230803000198
- ShareKRXDART:20230803000204
- ShareKRXDART:20230803000185
- 199,251 sharesKRXDART:20230803000182Canonical exit: 25 Oct 2023 (T+90)
- ShareKRXDART:20230803000194
- 199,251 sharesKRXDART:20230802000332Canonical exit: 25 Oct 2023 (T+90)
- 199,251 sharesKRXDART:20230731000444Canonical exit: 25 Oct 2023 (T+90)
- 199,251 sharesKRXDART:20230727000557Canonical exit: 25 Oct 2023 (T+90)
- 199,251 sharesKRXDART:20230727000495Canonical exit: 25 Oct 2023 (T+90)
17 of 17 declarations
About 파로스아이바이오
Paros I Bio is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions for disease treatment.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
